v3.26.1
WARRANTS
12 Months Ended
Dec. 31, 2025
Guarantees and Product Warranties [Abstract]  
WARRANTS

13. WARRANTS

 

A summary of warrant activity for the years ended December 31, 2025 and 2024 is presented below.

                
    Warrants   Weighted-
Average
Exercise Price
   Weighted-
Average
Remaining
Contractual
Life (Years)
 
Outstanding at January 1, 2024    405,094   $178.50    4.7 
Granted    71,794    118.39    5.0 
Forfeited    -    -      
Exercised    -    -      
Outstanding at December 31, 2024    476,888    162.68    3.9 
Granted    162,217    5.92    5.5 
Forfeited    -    -      
Exercised    -    -      
Outstanding at December 31, 2025    639,105   $122.89    3.2 

 

The following table summarizes information about common stock warrants outstanding at December 31, 2025:

                         
Outstanding   Exercisable 
       Weighted             
       Average   Weighted       Weighted 
       Remaining   Average       Average 
Exercise  Number   Contractual   Exercise   Number   Exercise 
Price  Outstanding   Life (Years)   Price   Exercisable   Price 
$5.92   162,217    4.0   $5.92    162,217   $5.92 
$118.39   422,337    3.0   $118.39    422,337   $118.39 
$160.74   54,498    2.8   $160.74    54,498   $160.74 
$118,125 - $656,250   53    0.9   $355,118    53   $355,118 
$5.92 - $656,250   639,105    3.2   $122.89    639,105   $122.89 

 

Warrant Issuances During 2025

 

During the year ended December 31, 2025, the Company issued warrants to purchase 0.2 million shares of Class A common stock at an exercise price of $5.92 per share, subject to adjustment, in connection with the issuance of Series G convertible preferred stock (the “Series G Preferred Stock”) to a related party (see Note 23).

 

Warrant Issuances During 2024

 

During the year ended December 31, 2024, the Company issued warrants to purchase 0.1 million shares of Class A common stock at an exercise price of $118.39 per share, subject to adjustment, in connection with the issuance of Series C convertible preferred stock (the “Series C Preferred Stock”) to a related party (see Note 23).

 

The Company utilized a variety of pricing models and the weighted average assumptions used during the years ended December 31, 2025 and 2024 were as follows:

          
   December 31,
2025
   December 31,
2024
 
Exercise price  $5.92   $118.39 
Contractual term in years   5.5    5.0 
Volatility   151%   153%
Dividend yield   0%   0%
Risk-free interest rate   4.4%   4.2%